Potassium chloride: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 1: Line 1:
{{DrugProjectFormSinglePage
{{DrugProjectFormSinglePage
|authorTag=<!--Overview-->
|genericName=generic name
|aOrAn=a
|aOrAn=a
|drugClass=Adrenergic receptor agonist
|indication=a list of indications, separated by commas.
|hasBlackBoxWarning=Yes
|hasBlackBoxWarning=Yes
|adverseReactions=<!--Black Box Warning-->
|adverseReactions=a list of adverse reactions, separated by commas.
|blackBoxWarningTitle=Title
|blackBoxWarningTitle=Warning Title
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
|blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content)
 
|fdaLIADAdult======Condition 1=====
* Content
 
<!--Adult Indications and Dosage-->
 
<!--FDA-Labeled Indications and Dosage (Adult)-->
|fdaLIADAdult======Condition1=====


* Dosing Information
* Dosing Information


:* Dosage
:* (Dosage)


=====Condition2=====
=====Condition 2=====


* Dosing Information
* Dosing Information


:* Dosage
:* (Dosage)
|offLabelAdultGuideSupport======Condition 1=====


=====Condition3=====
* Developed by: (Organisation)


* Dosing Information
* Class of Recommendation: (Class) (Link)


:* Dosage
* Strength of Evidence: (Category A/B/C) (Link)


=====Condition4=====
* Dosing Information/Recommendation


* Dosing Information
:* (Dosage)


:* Dosage
=====Condition 2=====


<!--Off-Label Use and Dosage (Adult)-->
* Developed by: (Organisation)


<!--Guideline-Supported Use (Adult)-->
* Class of Recommendation: (Class) (Link)
|offLabelAdultGuideSupport======Condition1=====


* Developed by:  
* Strength of Evidence: (Category A/B/C) (Link)


* Class of Recommendation:
* Dosing Information/Recommendation


* Strength of Evidence:
:* (Dosage)
|offLabelAdultNoGuideSupport======Condition 1=====


* Dosing Information
* Dosing Information


:* Dosage
:* (Dosage)


=====Condition2=====
=====Condition 2=====
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 
<!--Non–Guideline-Supported Use (Adult)-->
|offLabelAdultNoGuideSupport======Condition1=====


* Dosing Information
* Dosing Information


:* Dosage
:* (Dosage)


=====Condition2=====
=====Condition 3=====
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 
<!--Pediatric Indications and Dosage-->
 
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
|fdaLIADPed======Condition1=====


* Dosing Information
* Dosing Information


:* Dosage
:* (Dosage)
 
|fdaLIADPed======Condition 1=====
=====Condition2=====
 
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
 
<!--Off-Label Use and Dosage (Pediatric)-->
 
<!--Guideline-Supported Use (Pediatric)-->
|offLabelPedGuideSupport======Condition1=====
 
* Developed by:
 
* Class of Recommendation:
 
* Strength of Evidence:


* Dosing Information
* Dosing Information


:* Dosage
:* (Dosage)


=====Condition2=====
=====Condition 2=====
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 
<!--Non–Guideline-Supported Use (Pediatric)-->
|offLabelPedNoGuideSupport======Condition1=====


* Dosing Information
* Dosing Information


:* Dosage
:* (Dosage)
|offLabelPedGuideSupport======Condition 1=====


=====Condition2=====
* Developed by: (Organisation)


There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
* Class of Recommendation: (Class) (Link)


<!--Contraindications-->
* Strength of Evidence: (Category A/B/C) (Link)
|contraindications=* Condition1


<!--Warnings-->
* Dosing Information/Recommendation
|warnings=* Description


====Precautions====
:* (Dosage)


* Description
=====Condition 2=====


<!--Adverse Reactions-->
* Developed by: (Organisation)


<!--Clinical Trials Experience-->
* Class of Recommendation: (Class) (Link)
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.


=====Body as a Whole=====
* Strength of Evidence: (Category A/B/C) (Link)


* Dosing Information/Recommendation


:* (Dosage)
|offLabelPedNoGuideSupport======Condition 1=====


* Dosing Information


=====Cardiovascular=====
:* (Dosage)


=====Condition 2=====


* Dosing Information


:* (Dosage)


=====Digestive=====
=====Condition 3=====


* Dosing Information


:* (Dosage)
|contraindications=* Condition 1
* Condition 2
* Condition 3
* Condition 4
* Condition 5
|warnings======Conidition 1=====


(Description)


=====Endocrine=====
|clinicalTrials=======Central Nervous System======


: (list/description of adverse reactions)


======Cardiovascular======


: (list/description of adverse reactions)


=====Hematologic and Lymphatic=====
======Respiratory======


: (list/description of adverse reactions)


======Gastrointestinal======


: (list/description of adverse reactions)


=====Metabolic and Nutritional=====
======Hypersensitive Reactions======


: (list/description of adverse reactions)


======Miscellaneous======


: (list/description of adverse reactions)


=====Musculoskeletal=====
=====Condition 2=====


======Central Nervous System======


: (list/description of adverse reactions)


======Cardiovascular======


=====Neurologic=====
: (list/description of adverse reactions)


======Respiratory======


: (list/description of adverse reactions)


======Gastrointestinal======


=====Respiratory=====
: (list/description of adverse reactions)


======Hypersensitive Reactions======


: (list/description of adverse reactions)


======Miscellaneous======


=====Skin and Hypersensitivy Reactions=====
: (list/description of adverse reactions)
|postmarketing=(Description)
|drugInteractions=* Drug 1
* Drug 2
* Drug 3
* Drug 4
* Drug 5


=====Drug 1=====


(Description)


=====Drug 2=====


=====Special Senses=====
(Description)


=====Drug 3=====


(Description)


=====Drug 4=====


=====Urogenital=====
(Description)


=====Drug 5=====


(Description)
|useInPregnancyFDA=(Description)
|useInPregnancyAUS=(Description)
|useInLaborDelivery=(Description)
|useInNursing=(Description)
|useInPed=(Description)
|useInGeri=(Description)
|useInGender=(Description)
|useInRace=(Description)
|useInRenalImpair=(Description)
|useInHepaticImpair=(Description)
|useInReproPotential=(Description)
|useInImmunocomp=(Description)
|othersTitle=Others
|useInOthers=(Description)


|administration=(Oral/Intravenous/etc)
|monitoring======Condition 1=====


=====Miscellaneous=====
(Description regarding monitoring, from ''Warnings'' section)


=====Condition 2=====


(Description regarding monitoring, from ''Warnings'' section)


<!--Postmarketing Experience-->
=====Condition 3=====
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.


=====Body as a Whole=====
(Description regarding monitoring, from ''Warnings'' section)
|IVCompat====Solution===


====Compatible====


* Solution 1
* Solution 2
* Solution 3


=====Cardiovascular=====
====Not Tested====


* Solution 1
* Solution 2
* Solution 3


====Variable====


=====Digestive=====
* Solution 1
* Solution 2
* Solution 3


====Incompatible====


* Solution 1
* Solution 2
* Solution 3


=====Endocrine=====
===Y-Site===


====Compatible====


* Solution 1
* Solution 2
* Solution 3


=====Hematologic and Lymphatic=====
====Not Tested====


* Solution 1
* Solution 2
* Solution 3


====Variable====


=====Metabolic and Nutritional=====
* Solution 1
* Solution 2
* Solution 3


====Incompatible====


* Solution 1
* Solution 2
* Solution 3


=====Musculoskeletal=====
===Admixture===


====Compatible====


* Solution 1
* Solution 2
* Solution 3


=====Neurologic=====
====Not Tested====


* Solution 1
* Solution 2
* Solution 3


====Variable====


=====Respiratory=====
* Solution 1
* Solution 2
* Solution 3


====Incompatible====


* Solution 1
* Solution 2
* Solution 3


=====Skin and Hypersensitivy Reactions=====
===Syringe===


====Compatible====


* Solution 1
* Solution 2
* Solution 3


=====Special Senses=====
====Not Tested====


* Solution 1
* Solution 2
* Solution 3


====Variable====


=====Urogenital=====
* Solution 1
* Solution 2
* Solution 3


====Incompatible====


* Solution 1
* Solution 2
* Solution 3


=====Miscellaneous=====
===TPN/TNA===


====Compatible====


* Solution 1
* Solution 2
* Solution 3


<!--Drug Interactions-->
====Not Tested====
|drugInteractions=* Drug
:* Description


<!--Use in Specific Populations-->
* Solution 1
|useInPregnancyFDA=* '''Pregnancy Category'''
* Solution 2
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
* Solution 3


There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
====Variable====
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
|useInNursing=There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
|useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
|useInGender=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
|useInRace=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
|useInRenalImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
|useInHepaticImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.


<!--Administration and Monitoring-->
* Solution 1
|administration=* Oral
* Solution 2
* Solution 3


* Intravenous
====Incompatible====
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.


* Description
* Solution 1
 
* Solution 2
<!--IV Compatibility-->
* Solution 3
|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
 
<!--Overdosage-->
|overdose====Acute Overdose===
|overdose====Acute Overdose===


====Signs and Symptoms====
====Signs and Symptoms====


* Description
(Description)


====Management====
====Management====


* Description
(Description)


===Chronic Overdose===
===Chronic Overdose===


There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
====Signs and Symptoms====


<!--Pharmacology-->
(Description)


<!--Drug box 2-->
====Management====
|drugBox=[[File:Potassium chloride.png|600px|thumbnail|left]]
{{clear}}
|mechAction=*


<!--Structure-->
(Description)
|structure=*
|drugBox={{Drugbox2
| verifiedrevid =
| IUPAC_name =
| image =
| drug_name =  


: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
<!--Clinical data-->
| tradename =
| MedlinePlus =
| licence_US =
| pregnancy_AU =
| pregnancy_US =
| legal_status =
| routes_of_administration =


<!--Pharmacodynamics-->
<!--Pharmacokinetic data-->
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
| bioavailability =
| metabolism =
| elimination_half-life =
| excretion =  


<!--Pharmacokinetics-->
<!--Identifiers-->
|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
| CAS_number_Ref =
| CAS_number =
| ATC_prefix =
| ATC_suffix =
| PubChem =
| IUPHAR_ligand =
| DrugBank_Ref =
| DrugBank =
| ChemSpiderID_Ref =
| ChemSpiderID =
| UNII_Ref =
| UNII =
| KEGG_Ref =
| KEGG =
| ChEBI_Ref =
| ChEBI =
| ChEMBL_Ref =
| ChEMBL =  


<!--Nonclinical Toxicology-->
<!--Chemical data-->
|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
| C= | H= | N= | O=
| molecular_weight =
| smiles =
| InChI =
| InChIKey =
| StdInChI_Ref =
| StdInChI =
| StdInChIKey_Ref =
| StdInChIKey =
| melting_point =  
}}
|mechAction=(Description)
|structure=(Description with picture)
|PD=(Description)
|PK=(Description)
|nonClinToxic=(Description)
|clinicalStudies======Condition 1=====


<!--Clinical Studies-->
(Description)
|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.


<!--How Supplied-->
=====Condition 2=====
|howSupplied=*


<!--Patient Counseling Information-->
(Description)
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.


<!--Precautions with Alcohol-->
=====Condition 3=====
|alcohol=* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.


<!--Brand Names-->
(Description)
|brandNames=* ®<ref>{{Cite web | title = | url = }}</ref>
|howSupplied=(Description)
 
|fdaPatientInfo=(Patient Counseling Information)
<!--Look-Alike Drug Names-->
|nlmPatientInfo=(Link to patient information page)
|lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
|lookAlike=* (Paired Confused Name 1a) — (Paired Confused Name 1b)
 
* (Paired Confused Name 2a) — (Paired Confused Name 2b)
<!--Drug Shortage Status-->
* (Paired Confused Name 3a) — (Paired Confused Name 3b)
|drugShortage=
|drugShortage=Drug Shortage
}}
{{PillImage
|fileName=No image.jpg
}}
{{LabelImage
|fileName={{PAGENAME}}11.png
}}
{{LabelImage
|fileName={{PAGENAME}}11.png
}}
}}
<!--Pill Image-->
<!--Label Display Image-->
<!--Category-->
[[Category:Drug]]

Revision as of 19:06, 19 October 2014

Potassium chloride
Black Box Warning
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Black Box Warning

Warning Title
See full prescribing information for complete Boxed Warning.
Condition Name: (Content)

Overview

Potassium chloride is a Adrenergic receptor agonist that is FDA approved for the {{{indicationType}}} of a list of indications, separated by commas.. There is a Black Box Warning for this drug as shown here. Common adverse reactions include a list of adverse reactions, separated by commas..

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Condition 1
  • Dosing Information
  • (Dosage)
Condition 2
  • Dosing Information
  • (Dosage)

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

Condition 1
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)
Condition 2
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)

Non–Guideline-Supported Use

Condition 1
  • Dosing Information
  • (Dosage)
Condition 2
  • Dosing Information
  • (Dosage)
Condition 3
  • Dosing Information
  • (Dosage)

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Condition 1
  • Dosing Information
  • (Dosage)
Condition 2
  • Dosing Information
  • (Dosage)

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Condition 1
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)
Condition 2
  • Developed by: (Organisation)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)

Non–Guideline-Supported Use

Condition 1
  • Dosing Information
  • (Dosage)
Condition 2
  • Dosing Information
  • (Dosage)
Condition 3
  • Dosing Information
  • (Dosage)

Contraindications

  • Condition 1
  • Condition 2
  • Condition 3
  • Condition 4
  • Condition 5

Warnings

Warning Title
See full prescribing information for complete Boxed Warning.
Condition Name: (Content)
Conidition 1

(Description)

Adverse Reactions

Clinical Trials Experience

Central Nervous System
(list/description of adverse reactions)
Cardiovascular
(list/description of adverse reactions)
Respiratory
(list/description of adverse reactions)
Gastrointestinal
(list/description of adverse reactions)
Hypersensitive Reactions
(list/description of adverse reactions)
Miscellaneous
(list/description of adverse reactions)
Condition 2
Central Nervous System
(list/description of adverse reactions)
Cardiovascular
(list/description of adverse reactions)
Respiratory
(list/description of adverse reactions)
Gastrointestinal
(list/description of adverse reactions)
Hypersensitive Reactions
(list/description of adverse reactions)
Miscellaneous
(list/description of adverse reactions)

Postmarketing Experience

(Description)

Drug Interactions

  • Drug 1
  • Drug 2
  • Drug 3
  • Drug 4
  • Drug 5
Drug 1

(Description)

Drug 2

(Description)

Drug 3

(Description)

Drug 4

(Description)

Drug 5

(Description)

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): (Description)
Pregnancy Category (AUS): (Description)

Labor and Delivery

(Description)

Nursing Mothers

(Description)

Pediatric Use

(Description)

Geriatic Use

(Description)

Gender

(Description)

Race

(Description)

Renal Impairment

(Description)

Hepatic Impairment

(Description)

Females of Reproductive Potential and Males

(Description)

Immunocompromised Patients

(Description)

Others

(Description)

Administration and Monitoring

Administration

(Oral/Intravenous/etc)

Monitoring

Condition 1

(Description regarding monitoring, from Warnings section)

Condition 2

(Description regarding monitoring, from Warnings section)

Condition 3

(Description regarding monitoring, from Warnings section)

IV Compatibility

Solution

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Y-Site

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Admixture

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Syringe

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

TPN/TNA

Compatible

  • Solution 1
  • Solution 2
  • Solution 3

Not Tested

  • Solution 1
  • Solution 2
  • Solution 3

Variable

  • Solution 1
  • Solution 2
  • Solution 3

Incompatible

  • Solution 1
  • Solution 2
  • Solution 3

Overdosage

Acute Overdose

Signs and Symptoms

(Description)

Management

(Description)

Chronic Overdose

Signs and Symptoms

(Description)

Management

(Description)

Pharmacology

Chemical structure of Potassium chloride
Potassium chloride
Systematic (IUPAC) name
?
Identifiers
CAS number ?
ATC code ?
PubChem ?
Chemical data
Formula ?
Mol. mass ?
Pharmacokinetic data
Bioavailability ?
Metabolism ?
Half life ?
Excretion ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes ?

Mechanism of Action

(Description)

Structure

(Description with picture)

Pharmacodynamics

(Description)

Pharmacokinetics

(Description)

Nonclinical Toxicology

(Description)

Clinical Studies

Condition 1

(Description)

Condition 2

(Description)

Condition 3

(Description)

How Supplied

(Description)

Storage

There is limited information regarding Potassium chloride Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Potassium chloride |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Potassium chloride |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

(Patient Counseling Information)

Precautions with Alcohol

Alcohol-Potassium chloride interaction has not been established. Talk to your doctor regarding the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Potassium chloride Brand Names in the drug label.

Look-Alike Drug Names

  • (Paired Confused Name 1a) — (Paired Confused Name 1b)
  • (Paired Confused Name 2a) — (Paired Confused Name 2b)
  • (Paired Confused Name 3a) — (Paired Confused Name 3b)

Drug Shortage Status

Drug Shortage

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

Retrieved from "https://www.wikidoc.org/index.php?title=Potassium_chloride&oldid=1033422"